Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.64 |
| ▸ | PPARA | Q07869 | 3/20 | 0.60 |
| ▸ | TOP2A | P11388 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | PPARG | P37231 | 1/20 | 0.57 |
| ▸ | PPARD | Q03181 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20739903 | 1.00 | PTGS1 (0.64) | PTGS1PPARATOP2AMEN1KMT2A | |
| SCHEMBL20723797 | 1.00 | PTGS1 (0.64) | PTGS1PPARATOP2AMEN1KMT2A | |
| SCHEMBL20723701 | 1.00 | PTGS1 (0.64) | PTGS1PPARATOP2AMEN1KMT2A | |
| SCHEMBL20723822 | 1.00 | PTGS1 (0.64) | PTGS1PPARATOP2AMEN1KMT2A | |
| SCHEMBL20723700 | 0.99 | PTGS1 (0.66) | PTGS1PPARATOP2AMEN1KMT2A | |
| SCHEMBL11613528 | 0.95 | PTGS1 (0.67) | PTGS1PPARATOP2AMEN1KMT2A | |
| SCHEMBL9309996 | 0.94 | PTGS1 (0.58) | PTGS1PPARATOP2AMEN1KMT2A | |
| SCHEMBL20739828 | 0.94 | PTGS1 (0.58) | PTGS1PPARATOP2AMEN1KMT2A | |
| SCHEMBL31518883 | 0.94 | ALOX15 (0.66) | PTGS1PPARATOP2AMEN1KMT2A | |
| SCHEMBL20723823 | 0.90 | PTGS1 (0.64) | PTGS1PPARATOP2AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019030643-A1 | COMPOSITIONS OF EUGENOL DERIVATIVES FOR TREATMENT OF VISCERAL LEISHMANIASIS | FOUNDATION FOR NEGLECTED DISEASE RESEARCH (IN) | 2019-02-14 | — | — | WO | disclosed |
| EP-2280051-B1 | Secondary emulsifiers for inverted emulsion fluids and methods for making an using same | CLEARWATER INT LLC (US) | 2015-02-11 | — | — | EP | disclosed |
| US-8821908-B2 | Mold-resistant construction materials | HENKEL AG & CO. KGAA (DE) | 2014-09-02 | — | — | US | disclosed |
| EP-2280051-A1 | Secondary emulsifiers for inverted emulsion fluids and methods for making an using same | Clearwater International LLC (US) | 2011-02-02 | — | — | EP | disclosed |
| US-20110021385-A1 | SECONDARY EMULSIFIERS FOR INVERTED EMULSION FLUIDS AND METHODS FOR MAKING AND USING SAME | CLEARWATER INTERNATIONAL, LLC (US) | 2011-01-27 | — | — | US | disclosed |
| US-20110021385-A1 | SECONDARY EMULSIFIERS FOR INVERTED EMULSION FLUIDS AND METHODS FOR MAKING AND USING SAME | CLEARWATER INTERNATIONAL, LLC (US) | 2011-01-27 | — | — | US | disclosed |
| US-7557145-B2 | Inhibition of the asexual reproduction of fungi by eugenol and/or derivatives thereof | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2009-07-07 | — | — | US | disclosed |
| US-20070224250-A1 | MOLD-RESISTANT CONSTRUCTION MATERIALS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2007-09-27 | — | — | US | disclosed |
| US-20060128813-A1 | Inhibition of the asexual reproduction of fungi by eugenol and/or derivatives thereof | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2006-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070224250-A1 | MOLD-RESISTANT CONSTRUCTION MATERIALS | ERG28, DCXR, MGAM | PTGS1 1285/4885PPARA 4563/4885TOP2A 1270/4885 |
| US-20060128813-A1 | Inhibition of the asexual reproduction of fungi by eugenol and/or derivatives thereof | ERG28, MEP1A, ETF1 | PTGS1 2316/4885PPARA 3408/4885TOP2A 3232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.